MYGN

Myriad Genetics Inc (MYGN)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 546.17M
P/E Ratio
0.00
Revenue (TTM)
$ 832.9M
Volume
0
52W High
$ 29.30
52W Low
$ 3.76
Dividend Yield
0.00%
Beta
1.90

Technicals

50-Day MA
5.0546
200-Day MA
10.0297
52 Week High
29.3
52 Week Low
3.76

About MYGN

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Employees
2700
Headquarters
Salt Lake City, UT
CEO
Mr. Samraat S. Raha

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg